152 related articles for article (PubMed ID: 8995543)
1. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer.
Shimabukuro K; Toyama-Sorimachi N; Ozaki Y; Goi T; Furukawa K; Miyasaka M; Aso T
Gynecol Oncol; 1997 Jan; 64(1):26-34. PubMed ID: 8995543
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of CD44 splice variant expression in premalignant lesions of the cervix and benign cervical epithelium.
Kohlberger PD; Kieback DG; Bancher D; Stickeler E; Heinzl H; Gitsch G; Breitenecker G; Kainz C
Gynecol Oncol; 1997 Aug; 66(2):227-32. PubMed ID: 9264567
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours.
Saegusa M; Hashimura M; Machida D; Okayasu I
J Pathol; 1999 Jan; 187(2):173-83. PubMed ID: 10365092
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study.
Faleiro-Rodrigues C; Lopes C
Pathobiology; 2004; 71(6):329-36. PubMed ID: 15627844
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression.
Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K
Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431
[TBL] [Abstract][Full Text] [Related]
7. CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer.
Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T
Eur J Cancer; 1998 Dec; 34(13):2107-11. PubMed ID: 10070319
[TBL] [Abstract][Full Text] [Related]
8. CD44 expression in cervical intraepithelial neoplasia (CIN) and carcinoma.
Gorham H; Woodman A; Goodison S; Marsh J; Charnock M; Manek S; Sugino T; Tarin D
Mol Diagn; 1999 Mar; 4(1):45-56. PubMed ID: 10229774
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD44 in uterine cervical squamous neoplasia: a predictor of microinvasion?
Callagy G; O'Grady A; Butler D; Leader M; Kay E
Gynecol Oncol; 2000 Jan; 76(1):73-9. PubMed ID: 10620445
[TBL] [Abstract][Full Text] [Related]
10. Distribution of CD44 variant isoforms in human skin: differential expression in components of benign and malignant epithelia.
Hale LP; Patel DD; Clark RE; Haynes BF
J Cutan Pathol; 1995 Dec; 22(6):536-45. PubMed ID: 8835172
[TBL] [Abstract][Full Text] [Related]
11. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis.
Koyama S; Maruyama T; Adachi S
J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277
[TBL] [Abstract][Full Text] [Related]
12. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
[TBL] [Abstract][Full Text] [Related]
13. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia.
Dellas A; Schultheiss E; Almendral AC; Torhost J; Gudat F
Gynecol Oncol; 1996 Aug; 62(2):218-25. PubMed ID: 8751553
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G
Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of CD44 splice variants in human stage III cervical cancer.
Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G
Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of CD44v6 in adenocarcinoma of the pancreas: an immunohistochemical study.
Castellà EM; Ariza A; Ojanguren I; Mate JL; Roca X; Fernández-Vasalo A; Navas-Palacios JJ
Virchows Arch; 1996 Nov; 429(4-5):191-5. PubMed ID: 8972753
[TBL] [Abstract][Full Text] [Related]
18. CD44 loss in gastric stromal tumors as a prognostic marker.
Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
[TBL] [Abstract][Full Text] [Related]
19. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.
Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z
Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709
[TBL] [Abstract][Full Text] [Related]
20. Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence.
Gilcrease MZ; Guzman-Paz M; Niehans G; Cherwitz D; McCarthy JB; Albores-Saavedra J
Cancer; 1999 Dec; 86(11):2320-6. PubMed ID: 10590373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
